Ocugen Canada Ltd-Formerly Vaccigen Ltd Company Profile, Contacts & Intelligence

Ocugen Canada Ltd-Formerly Vaccigen Ltd Overview

Vaccigen Ltd is a Canadian Biopharmaceutical Company, a subsidiary of Ocugen Inc. Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug – “one to many” and our novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. We are co-developing Bharat Biotech’s COVAXIN™ vaccine candidate for COVID-19 in the Canadian and the U.S. market.

Headquarters

Toronto, Ontario, Ca

Website

www.vaccigen.ca

Industry

Biotechnology Research

Stock Symbol

OCGN

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Ocugen Canada Ltd-Formerly Vaccigen Ltd Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Ocugen Canada Ltd-Formerly Vaccigen Ltd People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to Ocugen Canada Ltd-Formerly Vaccigen Ltd

Explore companies in related markets and compare their industry and employee estimates.